Clinical Trial Update: Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Verteporfin in recurrent high-grade EGFR-mutated glioblastoma (Phase 1/2) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Verteporfin (verteporfin)

Snippet

Sponsor: Emory University | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING